+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gene Expression Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030

  • PDF Icon

    Report

  • 247 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5918320
The global gene expression market is on a robust growth trajectory, with the market value expected to surge from US$14.5 billion in 2022 to an estimated US$20.8 billion by 2030. This expansion is supported by a steady compound annual growth rate (CAGR) of 5.3% forecasted between 2023 and 2030.

Key Market Trends

1. Cancer Diagnostics and Treatment: A primary driver of market growth is the increasing demand for cancer diagnostics and treatment. The analysis of gene expression plays a crucial role in early cancer detection, utilizing abnormal gene expression patterns as biomarkers for cancer risk assessment and intervention.
2. Rise of Liquid Biopsies: The rapid expansion of liquid biopsies is another significant trend contributing to market growth. Liquid biopsies simplify treatment decisions by enabling oncologists to identify therapeutic targets and formulate tailored treatment plans based on gene expression analysis in liquid biopsy samples.
3. cDNA Synthesis & Conversion Dominance: In 2022, the cDNA synthesis & conversion category led the market, marking the first step in gene expression analysis by extracting total RNA from various biological samples, such as blood, tissues, and cells, to ensure successful cDNA synthesis.
4. Kits & Reagents Category: Kits & reagents represented the dominant category in 2022, featuring reagents and tests to assess RNA sample quality and reliability using techniques like gel electrophoresis and spectrophotometry.
5. High-Plex Capacity: High-plex gene expression analysis, achieved through advanced multiplexing technologies, allowed for the simultaneous detection and quantification of multiple genes or targets within a single sample, making it a leading trend in 2022.
6. Drug Discovery & Development: The drug discovery & development segment took the lead in 2022, as gene expression research identified potential applications for existing drugs by revealing therapeutic efficacy through gene expression patterns in various diseases.
7. RNA Expression Profiling: RNA expression profiling held prominence in 2022, enabled by high-throughput techniques like RNA-seq, offering unbiased profiling of the entire transcriptome.

Key Growth Determinants

1. Mounting Prevalence of Genetic Diseases: As the prevalence of genetic diseases increases, there is a growing need to understand the molecular mechanisms behind these conditions. Gene expression analysis aids in identifying overexpressed or under-expressed genes, paving the way for disease classification, diagnosis, and biomarker identification.
2. Rising Demand for Personalized Medicine: Gene expression analysis is a vital component of personalized medicine, allowing healthcare professionals to make informed treatment decisions based on a patient's genetic profile. This approach results in more efficient therapies, reduced side effects, and improved patient outcomes.
3. Technological Advancements: Advancements in gene expression analysis, particularly through next-generation sequencing (NGS) technologies like RNA-seq, have provided researchers with high-resolution data on gene expression levels. Ongoing innovations in NGS technologies enhance efficiency, speed, and accuracy, facilitating gene expression profiling.

Major Challenges

1. High Costs of Advanced Technologies: The high cost of modern gene expression techniques, such as single-cell RNA sequencing and NGS, can be prohibitive for research organizations, especially smaller academic labs and those with limited resources. Initial investments in high-end sequencing machines and ongoing expenses for reagents and data analysis can pose budget constraints.
2. Complex Data Analysis: Gene expression data analysis often requires bioinformatics and computational biology expertise. Integrating gene expression data with other omics data or clinical information can be challenging due to varying data formats and the need for advanced data integration methodologies.

Regional Highlights

1. North America Leads: North America is expected to dominate the gene expression market throughout the forecast period. Increased funding and expanding research and development efforts, especially in the United States, contribute to this growth. The region's focus on gene expression studies, government initiatives, and funding availability for NGS research further propel market expansion.
2. Asia Pacific's Rapid Growth: Asia Pacific is poised to be the fastest-growing region in the gene expression market, driven by increasing research investments and substantial populations in countries like China and India. These countries offer opportunities for individualized and advanced healthcare.

Competitive Landscape

The gene expression market is characterized by competition among several well-established manufacturers. Major corporations are expanding distribution networks, introducing new products, and pursuing market share growth strategies. Market consolidation is expected to continue in the coming years.

Leading Companies in the Global Gene Expression Space

  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific, Inc.
  • Catalent Inc.
  • QIAGEN
  • Quest Diagnostics, Inc.
  • Hoffmann-La Roche Ltd
  • Agilent Technologies
  • GE Healthcare
  • Promega Corp.
  • Luminex Corp.
  • Takara Bio, Inc.
  • Danaher Corp.
  • Oxford Nanopore Technologies

Global Gene Expression Market is Segmented as Below:

By Process:

  • Sample Collection
  • Purification
  • cDNA synthesis & conversion
  • PCR Analysis
  • Data analysis & interpretation

By Product:

  • Kits & Reagents
  • DNA Chips
  • Others

By Capacity:

  • Low- to Mid-Plex
  • High-Plex

By Application:

  • Drug Discovery & Development
  • Clinical Diagnostics
  • Biotech & Microbiology
  • Others

By Technique:

  • RNA Expression
  • Promoter Analysis
  • Posttranslational Modification Analysis

By Geographic Coverage:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Turkey
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • South Africa
  • Egypt
  • Nigeria
  • Rest of Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Gene Expression Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Gene Expression Market Outlook, 2018 - 2030
3.1. Global Gene Expression Market Outlook, by Process, Value (US$ Bn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Sample Collection
3.1.1.2. Purification
3.1.1.3. cDNA synthesis & conversion
3.1.1.4. PCR Analysis
3.1.1.5. Data analysis & interpretation
3.2. Global Gene Expression Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Kits & Reagents
3.2.1.2. DNA Chips
3.2.1.3. Others
3.3. Global Gene Expression Market Outlook, by Capacity, Value (US$ Bn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Low- to Mid-Plex
3.3.1.2. High-Plex
3.4. Global Gene Expression Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
3.4.1. Key Highlights Snacks
3.4.1.1. Drug Discovery & Development
3.4.1.2. Clinical Diagnostics
3.4.1.3. Biotech & Microbiology
3.4.1.4. Others
3.5. Global Gene Expression Market Outlook, by Technique, Value (US$ Bn), 2018 - 2030
3.5.1. Key Highlights Snacks
3.5.1.1. RNA Expression
3.5.1.2. Promoter Analysis
3.5.1.3. Posttranslational Modification Analysis
3.6. Global Gene Expression Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
3.6.1. Key Highlights
3.6.1.1. North America
3.6.1.2. Europe
3.6.1.3. Asia Pacific
3.6.1.4. Latin America
3.6.1.5. Middle East & Africa
4. North America Gene Expression Market Outlook, 2018 - 2030
4.1. North America Gene Expression Market Outlook, by Process, Value (US$ Bn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Sample Collection
4.1.1.2. Purification
4.1.1.3. cDNA synthesis & conversion
4.1.1.4. PCR Analysis
4.1.1.5. Data analysis & interpretation
4.2. North America Gene Expression Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Kits & Reagents
4.2.1.2. DNA Chips
4.2.1.3. Others
4.3. North America Gene Expression Market Outlook, by Capacity, Value (US$ Bn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Low- to Mid-Plex
4.3.1.2. High-Plex
4.4. North America Gene Expression Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
4.4.1. Key Highlights
4.4.1.1. Drug Discovery & Development
4.4.1.2. Clinical Diagnostics
4.4.1.3. Biotech & Microbiology
4.4.1.4. Others
4.5. Global Gene Expression Market Outlook, by Technique, Value (US$ Bn), 2018 - 2030
4.5.1. Key Highlights Snacks
4.5.1.1. RNA Expression
4.5.1.2. Promoter Analysis
4.5.1.3. Posttranslational Modification Analysis
4.5.2. BPS Analysis/Market Attractiveness Analysis
4.6. North America Gene Expression Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
4.6.1. Key Highlights
4.6.1.1. U.S. Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
4.6.1.2. U.S. Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
4.6.1.3. U.S. Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
4.6.1.4. U.S. Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
4.6.1.5. U.S. Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
4.6.1.6. Canada Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
4.6.1.7. Canada Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
4.6.1.8. Canada Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
4.6.1.9. Canada Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
4.6.1.10. Canada Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
4.6.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Gene Expression Market Outlook, 2018 - 2030
5.1. Europe Gene Expression Market Outlook, by Process, Value (US$ Bn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Sample Collection
5.1.1.2. Purification
5.1.1.3. cDNA synthesis & conversion
5.1.1.4. PCR Analysis
5.1.1.5. Data analysis & interpretation
5.2. Europe Gene Expression Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Kits & Reagents
5.2.1.2. DNA Chips
5.2.1.3. Others
5.3. Europe Gene Expression Market Outlook, by Capacity, Value (US$ Bn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Low- to Mid-Plex
5.3.1.2. High-Plex
5.4. Europe Gene Expression Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
5.4.1. Key Highlights
5.4.1.1. Drug Discovery & Development
5.4.1.2. Clinical Diagnostics
5.4.1.3. Biotech & Microbiology
5.4.1.4. Others
5.5. Global Gene Expression Market Outlook, by Technique, Value (US$ Bn), 2018 - 2030
5.5.1. Key Highlights Snacks
5.5.1.1. RNA Expression
5.5.1.2. Promoter Analysis
5.5.1.3. Posttranslational Modification Analysis
5.5.2. BPS Analysis/Market Attractiveness Analysis
5.6. Europe Gene Expression Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
5.6.1. Key Highlights
5.6.1.1. Germany Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
5.6.1.2. Germany Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
5.6.1.3. Germany Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
5.6.1.4. Germany Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
5.6.1.5. Germany Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
5.6.1.6. U.K. Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
5.6.1.7. U.K. Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
5.6.1.8. U.K. Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
5.6.1.9. U.K. Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
5.6.1.10. U.K. Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
5.6.1.11. France Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
5.6.1.12. France Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
5.6.1.13. France Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
5.6.1.14. France Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
5.6.1.15. France Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
5.6.1.16. Italy Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
5.6.1.17. Italy Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
5.6.1.18. Italy Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
5.6.1.19. Italy Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
5.6.1.20. Italy Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
5.6.1.21. Turkey Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
5.6.1.22. Turkey Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
5.6.1.23. Turkey Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
5.6.1.24. Turkey Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
5.6.1.25. Turkey Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
5.6.1.26. Russia Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
5.6.1.27. Russia Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
5.6.1.28. Russia Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
5.6.1.29. Russia Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
5.6.1.30. Russia Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
5.6.1.31. Rest of Europe Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
5.6.1.32. Rest of Europe Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
5.6.1.33. Rest of Europe Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
5.6.1.34. Rest of Europe Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
5.6.1.35. Rest of Europe Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
5.6.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Gene Expression Market Outlook, 2018 - 2030
6.1. Asia Pacific Gene Expression Market Outlook, by Process, Value (US$ Bn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Sample Collection
6.1.1.2. Purification
6.1.1.3. cDNA synthesis & conversion
6.1.1.4. PCR Analysis
6.1.1.5. Data analysis & interpretation
6.2. Asia Pacific Gene Expression Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Kits & Reagents
6.2.1.2. DNA Chips
6.2.1.3. Others
6.3. Asia Pacific Gene Expression Market Outlook, by Capacity, Value (US$ Bn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. Low- to Mid-Plex
6.3.1.2. High-Plex
6.4. Asia Pacific Gene Expression Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
6.4.1. Key Highlights
6.4.1.1. Drug Discovery & Development
6.4.1.2. Clinical Diagnostics
6.4.1.3. Biotech & Microbiology
6.4.1.4. Others
6.5. Global Gene Expression Market Outlook, by Technique, Value (US$ Bn), 2018 - 2030
6.5.1. Key Highlights Snacks
6.5.1.1. RNA Expression
6.5.1.2. Promoter Analysis
6.5.1.3. Posttranslational Modification Analysis
6.5.2. BPS Analysis/Market Attractiveness Analysis
6.6. Asia Pacific Gene Expression Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
6.6.1. Key Highlights
6.6.1.1. China Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
6.6.1.2. China Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
6.6.1.3. China Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
6.6.1.4. China Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
6.6.1.5. China Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
6.6.1.6. Japan Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
6.6.1.7. Japan Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
6.6.1.8. Japan Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
6.6.1.9. Japan Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
6.6.1.10. Japan Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
6.6.1.11. South Korea Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
6.6.1.12. South Korea Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
6.6.1.13. South Korea Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
6.6.1.14. South Korea Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
6.6.1.15. South Korea Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
6.6.1.16. India Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
6.6.1.17. India Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
6.6.1.18. India Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
6.6.1.19. India Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
6.6.1.20. India Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
6.6.1.21. Southeast Asia Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
6.6.1.22. Southeast Asia Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
6.6.1.23. Southeast Asia Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
6.6.1.24. Southeast Asia Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
6.6.1.25. Southeast Asia Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
6.6.1.26. Rest of Asia Pacific Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
6.6.1.27. Rest of Asia Pacific Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
6.6.1.28. Rest of Asia Pacific Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
6.6.1.29. Rest of Asia Pacific Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
6.6.1.30. Rest of Asia Pacific Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
6.6.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Gene Expression Market Outlook, 2018 - 2030
7.1. Latin America Gene Expression Market Outlook, by Process, Value (US$ Bn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Sample Collection
7.1.1.2. Purification
7.1.1.3. cDNA synthesis & conversion
7.1.1.4. PCR Analysis
7.1.1.5. Data analysis & interpretation
7.2. Latin America Gene Expression Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Kits & Reagents
7.2.1.2. DNA Chips
7.2.1.3. Others
7.3. Latin America Gene Expression Market Outlook, by Capacity, Value (US$ Bn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Low- to Mid-Plex
7.3.1.2. High-Plex
7.4. Latin America Gene Expression Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
7.4.1. Key Highlights
7.4.1.1. Drug Discovery & Development
7.4.1.2. Clinical Diagnostics
7.4.1.3. Biotech & Microbiology
7.4.1.4. Others
7.5. Global Gene Expression Market Outlook, by Technique, Value (US$ Bn), 2018 - 2030
7.5.1. Key Highlights Snacks
7.5.1.1. RNA Expression
7.5.1.2. Promoter Analysis
7.5.1.3. Posttranslational Modification Analysis
7.5.2. BPS Analysis/Market Attractiveness Analysis
7.6. Latin America Gene Expression Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
7.6.1. Key Highlights
7.6.1.1. Brazil Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
7.6.1.2. Brazil Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
7.6.1.3. Brazil Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
7.6.1.4. Brazil Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
7.6.1.5. Brazil Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
7.6.1.6. Mexico Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
7.6.1.7. Mexico Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
7.6.1.8. Mexico Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
7.6.1.9. Mexico Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
7.6.1.10. Mexico Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
7.6.1.11. Argentina Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
7.6.1.12. Argentina Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
7.6.1.13. Argentina Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
7.6.1.14. Argentina Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
7.6.1.15. Argentina Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
7.6.1.16. Rest of Latin America Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
7.6.1.17. Rest of Latin America Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
7.6.1.18. Rest of Latin America Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
7.6.1.19. Rest of Latin America Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
7.6.1.20. Rest of Latin America Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
7.6.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Gene Expression Market Outlook, 2018 - 2030
8.1. Middle East & Africa Gene Expression Market Outlook, by Process, Value (US$ Bn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Sample Collection
8.1.1.2. Purification
8.1.1.3. cDNA synthesis & conversion
8.1.1.4. PCR Analysis
8.1.1.5. Data analysis & interpretation
8.2. Middle East & Africa Gene Expression Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Kits & Reagents
8.2.1.2. DNA Chips
8.2.1.3. Others
8.3. Middle East & Africa Gene Expression Market Outlook, by Capacity, Value (US$ Bn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. Low- to Mid-Plex
8.3.1.2. High-Plex
8.4. Middle East & Africa Gene Expression Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
8.4.1. Key Highlights
8.4.1.1. Drug Discovery & Development
8.4.1.2. Clinical Diagnostics
8.4.1.3. Biotech & Microbiology
8.4.1.4. Others
8.5. Global Gene Expression Market Outlook, by Technique, Value (US$ Bn), 2018 - 2030
8.5.1. Key Highlights Snacks
8.5.1.1. RNA Expression
8.5.1.2. Promoter Analysis
8.5.1.3. Posttranslational Modification Analysis
8.5.2. BPS Analysis/Market Attractiveness Analysis
8.6. Middle East & Africa Gene Expression Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
8.6.1. Key Highlights
8.6.1.1. GCC Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
8.6.1.2. GCC Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
8.6.1.3. GCC Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
8.6.1.4. GCC Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
8.6.1.5. GCC Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
8.6.1.6. South Africa Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
8.6.1.7. South Africa Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
8.6.1.8. South Africa Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
8.6.1.9. South Africa Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
8.6.1.10. South Africa Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
8.6.1.11. Egypt Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
8.6.1.12. Egypt Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
8.6.1.13. Egypt Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
8.6.1.14. Egypt Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
8.6.1.15. Egypt Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
8.6.1.16. Nigeria Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
8.6.1.17. Nigeria Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
8.6.1.18. Nigeria Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
8.6.1.19. Nigeria Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
8.6.1.20. Nigeria Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
8.6.1.21. Rest of Middle East & Africa Gene Expression Market by Process, Value (US$ Bn), 2018 - 2030
8.6.1.22. Rest of Middle East & Africa Gene Expression Market, by Product, Value (US$ Bn), 2018 - 2030
8.6.1.23. Rest of Middle East & Africa Gene Expression Market, by Capacity, Value (US$ Bn), 2018 - 2030
8.6.1.24. Rest of Middle East & Africa Gene Expression Market, by Application, Value (US$ Bn), 2018 - 2030
8.6.1.25. Rest of Middle East & Africa Gene Expression Market, by Technique, Value (US$ Bn), 2018 - 2030
8.6.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs Application Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Illumina, Inc.
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. PerkinElmer, Inc.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Bio-Rad Laboratories
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Thermo Fisher Scientific, Inc.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Catalent Inc.
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. QIAGEN
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Quest Diagnostics, Inc.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. F. Hoffmann-La Roche Ltd.
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Agilent Technologies
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. GE Healthcare
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Promega Corp.
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Luminex Corp.
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Takara Bio, Inc.
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. Danaher Corp.
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
9.4.15. Oxford Nanopore Technologies
9.4.15.1. Company Overview
9.4.15.2. Product Portfolio
9.4.15.3. Financial Overview
9.4.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific, Inc.
  • Catalent Inc.
  • QIAGEN
  • Quest Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies
  • GE Healthcare
  • Promega Corp.
  • Luminex Corp.
  • Takara Bio, Inc.
  • Danaher Corp.
  • Oxford Nanopore Technologies

Methodology

Loading
LOADING...